imipenem/relebactam/cilastatin

imipenem/relebactam/cilastatin · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for imipenem/relebactam/cilastatin, covering 2020-04-16 to 2020-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) [Phase 3]

See pricing